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Women’s health has traditionally been
t h o u g h to fi nt h er e a l mo fr e p r o d u c -
tive health, and that includes women’s
mental health (i.e., perinatal psychiatry).
However, we now know there are sig-
niﬁcant sex differences in many chronic
diseases, including brain disorders. Thus,
understanding the causes of sex differ-
ences in disorders of the brain, within
and outside of reproduction, is critical
to understanding women’s mental health
and healthcare needs. In order to accom-
plish this, it is necessary for neuroscience
to adopt a “sex-dependent” and/or “sex-
speciﬁc” lens on investigations of the
brain. In this review, we make the case for
depression, which has among the largest
sex differences in disorders of the brain.
Major depressive disorder (MDD)
recently became the number one cause of
disability worldwide (Murray and Lopez,
1997; Ustun et al., 2004; World Health
Organization, 2012). Importantly, the
incidence of MDD in women is twice
that of men (Kessler, 2003; Kendler et al.,
2006), and thus understanding its patho-
physiology has widespread implications
for attenuation and prevention of dis-
ease burden, particularly in women. Over
40 years of research implicate hormonal
dysregulation underlying mood disorders
(Board et al., 1956; Gibbons and McHugh,
1962; Coplan et al., 2000; Brouwer et al.,
2005; Kurt et al., 2007; Barim et al., 2009),
particularly involvement of hypothalamic-
pituitary-adrenal (HPA) and HP-gonadal
(HPG) axes (Board et al., 1956; Gibbons
and McHugh, 1962; Plotsky et al., 1998;
Young and Korszun, 2002; Swaab et al.,
2005). Central dysregulation of hormonal
axes can precede MDD onset suggest-
ing a role for hormonal abnormalities
in female MDD vulnerability. Ours and
others’ work demonstrated that the vul-
nerability for sex-dependent risk for MDD
begins in fetal development (McClellan
et al., 2010; Goldstein et al., 2011; Zuloaga
et al., 2012a,b; Carbone and Handa, 2013;
Seney et al., 2013). Despite these ﬁndings,
a number of confounds (state vs. trait,
treatment, age, and recurrence) present
challenges to elucidating the contribution
of hormonal or genetic sex (Seney et al.,
2013) to the co-occurrence of hormonal
dysregulation and mood disorders.
HPA AXIS IMPLICATED IN MDD
A central role for the HPA axis in
MDD was initially expressed clinically.
Depressive symptoms/MDD co-occurred
with endogenously elevated cortisol
(Sonino et al., 1998)o re x o g e n o u s l y
administered corticosteroids (Kelly et al.,
1980; Ling et al., 1981). Studies demon-
strated elevated levels of cortisol in
plasma, CSF, and 24-h urine samples, high
CSF corticotrophin releasing hormone
(CRH) levels, blunted responses to CRH
administration, and non-suppression of
cortisol secretion on the dexametha-
sone suppression test in MDD (Carroll
et al., 1976, 1981; Jarrett et al., 1983;
Nemeroff et al., 1984; Halbreich et al.,
1985; Holsboer et al., 1985; Banki et al.,
1987; Evans and Nemeroff, 1987; Rubin
et al., 1987; Heim et al., 2001; Newport
et al., 2003; Raison and Miller, 2003).
HPA axis dysregulation was related to age
(Nelson et al., 1984a,b; Bremmer et al.,
2007), depression subtype (Brouwer et al.,
2005), recurrence (Poor et al., 2004),
and treatment response, albeit inconsis-
tently (Nemeroff et al., 1991; De Bellis
et al., 1993; Veith et al., 1993; McKay
and Zakzanis, 2010). One potential con-
foundwaswhetherHPAaxisdysregulation
reﬂected clinical state or diagnostic trait.
A meta-analysis of >1500 individuals
(Vreeburg et al., 2009), demonstrated that
hypercortisolemia, present in currently
depressed individuals (Trestman et al.,
1993; Ahrens et al., 2008), persisted after
recovery (Vreeburg et al., 2009), while
other studies reported abnormal blunted
cortisol response to stress in recurrent
cases (Ahrens et al., 2008). In either case,
ﬁndings suggested HPA dysregulation as
a trait. In contrast, some studies showed
resolution of hypercortisolemia with treat-
ment (Vythilingam et al., 2004; Lok et al.,
2012), arguing that HPA dysregulation
was due to clinical state. Elevated baseline
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cortisol, enhanced CRH sensitivity, and
lack of responsivity to dexamethasone
suppression also predicted relapse vul-
nerability and sustained remission (Zobel
et al., 1999; Appelhof et al., 2006; Ising
et al., 2007). Despite this evidence, HPA-
axis targeted treatments are not reliably
effective in MDD, although show some
success as anti-depressant adjuncts (Jahn
et al., 2004) or improvement of cognitive
deﬁcits (Young et al., 2004).
Despite substantial data supporting sex
differences in HPA functioning during
stress in healthy populations (Kudielka
and Kirschbaum, 2005; Goldstein et al.,
2010)a n dM D Dw o m e n( Holsen et al.,
2011, 2013), reports of sex differences
in the HPA axis and MDD are incon-
sistent. Men, but not women, with
MDD demonstrated increased ACTH
pulsatility (Young et al., 2007a)a n d
elevated cortisol compared with non-
depressed men and women (Bremmer
et al., 2007; Hinkelmann et al., 2012).
However, depressed women vs. men (Poor
et al., 2004) and non-depressed women
(Young and Altemus, 2004; Chopra
et al., 2009) also expressed hypercor-
tisolemia. Study inconsistencies may
be related to timing of cortisol assess-
ments or may reﬂect methodological
confounds, such as age of study subjects
(e.g., post-menopausal women differ from
premenopausal women and thus sex dif-
ferences differ), chronicity of illness (e.g.,
sustained illness may produce blunted
cortisol response rather than hypercor-
tisolemia), or low statistical power to
detect sex differences which may vary in
effect size, depending on characteristics
of the sample (details next paragraph).
Further, genetic background likely affects
HPA axis dysregulation, as demon-
strated in studies showing increased
ACTH and cortisol in males (but not
females) homozygotic for the alpha(2)-
adrenoreceptor gene and females (but
not males) homozygotic for the beta(2)-
adrenoreceptor gene(Haefneretal.,2008).
Collectively, these ﬁndings offer initial evi-
dence of sex differences in the role of
HPA axis in MDD pathophysiology and
emphasize the importance of considering
genetic variation in HPA axis-associated
genes.
Some studies report no effect of sex on
HPA axis deﬁcits in MDD (Carroll et al.,
1976; Nelson et al., 1984b; Dahl et al.,
1989; Maes et al., 1994; Deuschle et al.,
1998; Brouwer et al., 2005; Vreeburg et al.,
2009),althoughsomeofthesestudieswere
not designed initially to investigate sex dif-
ferences, introducing potential confounds,
such as: oversampling women (thus small
samples of men) and low statistical power
to test for sex differences (Brouwer et al.,
2005; Young et al., 2007a; Vreeburg et al.,
2009; Hinkelmann et al., 2012); lack of
control for use of oral contraceptives
orestrogen-replacementtherapy(Brouwer
et al., 2005) affecting plasma cortisol levels
(Kirschbaum et al., 1999); and disregard
for menstrual cycle phase or menopausal
status during data collection. These con-
founds present signiﬁcant challenges to
understanding study inconsistencies on
sex differences in HPA-MDD associations
and their implications for women’s mental
health.
HPG AXIS IMPLICATED IN MDD
Post-puberty adolescence is a key period
during which sex differences in MDD
begin to emerge, initially during ages 13–
15, with the largest increase in late adoles-
cence (e.g., Hankin et al., 1998). However,
few studies have focused on understand-
ing why the higher rate of MDD in girls
than boys is initiated during this period.
This is unfortunate since puberty is an
important critical period for brain plas-
ticity likely arising from differential ﬂood-
ing of the brain with gonadal hormones
(Schulz et al., 2009), and further sexual
differentiation of the brain as the pre-
frontal cortex fully develops during ages
18–22 years. Evidence for HPG axis-MDD
associations also came from studies of
polycystic ovarian syndrome (Himelein
and Thatcher, 2006) and literature relat-
ingwomen’sreproductivebiologytomood
ﬂuctuationsanddepression(Steiner,1992;
Bloch et al., 2000; Payne, 2003; Angold
and Costello, 2006; Young et al., 2007b;
Graziottin and Seraﬁni, 2009; Brummelte
and Galea, 2010). Although there has
been less examination of HPG deﬁcits
in MDD in men, lower testosterone has
been reported (Schweiger et al., 1999;
Seidman et al., 2001). HPG dysregulation
in MDD has included androgens (Baischer
et al., 1995; Rubinow and Schmidt, 1996;
Schweigeretal.,1999;Seidmanetal.,2001;
Weiner et al., 2004), estrogens (Young
et al., 2000), and pituitary function (Daly
et al., 2003). Women with persistent
MDD had two times the risk of earlier
perimenopausal transition, higher FSH,
and lower estradiol levels, suggesting an
early decline in ovarian function (Young
et al., 2000; Harlow et al., 2003). Further,
depressive symptom severity was associ-




Dysregulation of HPA and HPG axes
interact in MDD. Low levels of estra-
diol with unopposed progesterone in
premenopausal MDD was associated
with decreased inhibitory feedback on
HPA function during stress, resulting
in elevated cortisol in MDD compared
to healthy women or men (Young and
Altemus, 2004). Transient dysregulation
of HPA axis during the luteal menstrual
phase was reported in premenstrual syn-
drome (Rabin et al., 1990; Roca et al.,
2003). Further, using functional MRI,
our group showed hypoactivity in stress-
responsive regions in premenopausal
MDD women was signiﬁcantly associated
with decreased estradiol and increased
progesterone levels during the late fol-
licular menstrual phase (Holsen et al.,
2011). In perimenopausal MDD women,
these brain regions were associated
with hypercortisolemia and hyperactivity
(Holsen et al., 2013). These imaging stud-
ies suggest a complex interplay between
HPA and HPG axes, dependent on age
and cycle timing. From a brain circuitry
point of view, MDD involves hypothala-
mic (HYPO) nuclei (paraventricular and
ventromedial), central amygdala (AMYG),
hippocampus (HIPP), anterior cingulate,
medial and orbital prefrontal cortices
(ACC, mPFC, OFC) (Dougherty and
Rauch,1997;Mayberg,1997;Drevetsetal.,
2002; Sheline et al., 2002; Rauch et al.,
2003), regions dense in glucocorticoid and
sex steroid hormone receptors (MacLusky
et al., 1987; Clark et al., 1988; Handa et al.,
1994; Kawata, 1995; Tobet and Hanna,
1997; Donahue et al., 2000; Östlund et al.,
2003). These regions develop in sex-
dependent ways, in part driven by gonadal
hormones. There is now a substantial
body of functional imaging work relat-
ing regulation of mood with endocrine
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function, e.g., Goldstein et al., 2005, 2010;
Protopopescu et al., 2005; Amin et al.,
2006; Stark et al., 2006; Dreher et al., 2007;
Wang et al., 2007; Pruessner et al., 2008;
van Wingen et al., 2008a,b, 2009; Root
et al., 2009; Andreano and Cahill, 2010.
SHARED MOOD AND ENDOCRINE
CIRCUITRY ARE SEXUALLY DIMORPHIC
In vivo imaging and postmortem studies
demonstrated sex differences in brain vol-
umes(ornuclei)ofregionsassociatedwith
MDD, althoughthere is littleworkfocused
on sexual dimorphisms in MDD per se. In
healthy women compared with men,r e l a -
tive to cerebrum size, ﬁndings supported
greater relative volumes of HIPP (Filipek
et al., 1994; Giedd et al., 1996; Murphy
et al., 1996; Goldstein et al., 2001), ACC
(Paus et al., 1996; Goldstein et al., 2001),
and OFC (Goldstein et al., 2001). In men,
there are relatively greater volumes of
AMYG (Giedd et al., 1996; Goldstein
et al., 2001), HYPO (Swaab and Fliers,
1985; Allen et al., 1989; Goldstein et al.,
2001), and paracingulate gyrus (Goldstein
et al., 2001; Paus et al., 1996). Recently,
a number of new studies have emerged
further characterizing sex-dependent cir-
cuitry (Ruigrok et al., 2013), connectivity
(Ingalhalikar et al., 2014), and poten-
tial mechanisms (Raznahan et al., 2010;
Kang et al., 2011; Goldstein et al., 2013;
Lenz et al., 2013; Nguyen et al., 2013).
Developmental pathways involve, in part,
gonadal hormone regulation, seen in
model animal (McEwen, 1983; Simerly
et al., 1990; Tobet et al., 1993, 2009;
O’Keefeetal.,1995;Parketal.,1996;Tobet
and Hanna, 1997; Gorski, 2000; Chung
et al., 2006)a n dh u m a n( Goldstein et al.,
2001; Raznahan et al., 2010)d e v e l o p m e n t .
In fact, preclinical studies demonstrated
lasting effects of prenatal adverse events
on HPA axis and noradrenergic stress sys-
tems (Takahashi et al., 1992; Weinstock
et al., 1992; Vallee et al., 1997; Weinstock,
1997). These included hypothalamic and
hippocampal structure and function
(Takahashi et al., 1992; Matsumoto and
Arai, 1997; Weinstock, 1997), with effects
that occurred through programming
a “hyperactive” system more vulnera-
ble to adult depressive and anxiety-like
behaviors and autonomic nervous sys-
tem deﬁcits, among others (Weinstock
et al., 1992; Henry et al., 1994; Barker,
1995; Seckl, 2001; Majdic and Tobet, 2011;
Zuloaga et al., 2011; Carbone et al., 2012).
Analogous to timing of these events in
animals, mid-to-late gestation in humans
is a particularly vulnerable time for the
impactofprenataleventsonsex-dependent
brain development (Tobet et al., 2009;
Majdic and Tobet, 2011; Zuloaga et al.,
2011; Carbone et al., 2012), and recent
preclinical and clinical studies implicated
earlier gestation (Mueller and Bale, 2008;
Howerton et al., 2013).
Preclinical studies also demonstrated
sex differences (greater in females than
males) in a number of domains, includ-
ing: (1) greater placental glucocorticoid
transfer (Montano et al., 1993; Fameli
etal.,1994);(2)greaterimmobilityintasks
associated with MDD phenotypic behav-
ior (Alonso et al., 2000); (3) increased
ACTH, corticosterone, and glucocorticoid
receptor binding (Weinstock et al., 1992;
McCormick et al., 1995; Regan et al.,
2004); (4) increased corticosterone sen-
sitivity (Rhodes and Rubin, 1999); (5)
greater susceptibility to changes follow-
ing loss of GABAB receptor function
(McClellan et al., 2010; Stratton et al.,
2011); (6) greater susceptibility to cell
death in AMYG following developmen-
tal exposure to dexamethasone (Zuloaga
et al., 2011); and (8) greater suscepti-
bility to diet-induced hepatosteatosis and
insulin growth factor-1 deﬁcits (Carbone
et al., 2012). In humans, at the level of
the brain, there have been fewer studies
of sex differences in MDD, although some
reported decreased HIPP and increased
AMYG volumes, greater in females than
males (Vakili et al., 2000; Janssen et al.,
2004; Weniger et al., 2006). Collectively,
preclinical studies support the hypothe-
sis that prenatal exposures (particularly
those implicating stress circuitry path-
ways) facilitate altered programming of
stress-related endocrine and neural cir-
cuits implicated in the sex-dependent
development of depressive-like behavior.
Although parallel studies in humans are
still in their infancy, we and others are
currentlytestingthehypothesisthatprena-
tal maternal disruption of stress-immune
pathways will, in the context of genetic
background, result in vulnerability for the
sex-dependent risk for MDD in the off-
spring (Handa et al., 1994; Majdic and
Tobet, 2011).
CONCLUSIONS
The number one cause of disability world-
wide is MDD, and women are two times
the risk of men. This represents ∼350
million people worldwide, approximately
16 million in the U.S. alone (WHO
October 2012 Fact Sheet). Depression is
comorbid with many chronic diseases
that are also associated sex differences in
risk (Goldstein et al., 2011, 2013). Thus,
depression is a major public health prob-
lem with substantial economic, social and
disease burden that, we argue, requires
a sex-dependent lens to understand its
pathophysiology. There are key natural-
istic opportunities for the study of this
higher risk in women, and that is when
the brain is differentially ﬂooded with
or depleted of gonadal hormones, i.e.,
fetal development, puberty, pregnancy,
and perimenopausal-menopause transi-
tion. The evidence brieﬂy discussed here
supports the hypothesis that the etiol-
ogy of sex differences in MDD begins
in fetal development and emerges post-
puberty. Its onset can be catalyzed by
pregnancy (postpartum depression) and
the menopausal transition (when there
is an increase in MDD onset). The
fact that these particular periods dur-
ing the lifespan have signiﬁcant implica-
tions for MDD onset is consistent with
an important role for steroid hormones
in MDD. This underscores the impor-
tance of promoting further inquiry into
the development of adjunctive neuroen-
docrine treatments, dependent on tim-
ing across the lifespan. This lifespan
approach to studying sex differences in
disorders, like depression, also illustrates
how maternal health (e.g., pregnancy),
women’s mental health, and sex differ-
ences in disorders of the brain are linked.
T h u s ,w eh a v ea r g u e dt h ei m p o r t a n c e
for preclinical and clinical neuroscience
to incorporate a sex-dependent and/or
sex-speciﬁc lens on investigations rang-
ing from the cellular-molecular level to
circuitry, systems, and behavior, an argu-
ment that recently was underscored by the
n e wd i r e c t i v ef r o mN I Ht oi n c o r p o r a t e
this perspective in designs of preclinical
studies (Clayton and Collins, 2014). We
believe this will provide the basis for the
development of sex-dependent therapeu-
tics which will enhance progress to greater
efﬁcacy.
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